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Figure 1: Kaplan-Meier curves depicting biochemical disease-free survival for different categories of
predictor variables.
Figure 2: Calibration plots depicting the observed versus the predicted probability of biochemical
disease-free survival (bDFS) at 24, 36, 48 and 60 months, respectively. The grey line is the optimal
line for complete concordance between observed and predicted bDFS. On the X-axis, the distribution
of predictions is depicted.
Figure 3: Biochemical disease free survival (bDFS) proportion for different categories of the predictor
variables disease-free survival interval after primary therapy (DFSI) and PSA doubling time (PSADT).
The 75% bDFS line is indicated.
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